✦ LIBER ✦

The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guérin Instillation Therapy on the Quality of Life in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial

✍ Scribed by Gontero, Paolo; Oderda, Marco; Mehnert, Anja; Gurioli, Alberto; Marson, Francesco; Lucca, Ilaria; Rink, Michael; Schmid, Marianne; Kluth, Luis A.; Pappagallo, Giovanni; Sogni, Filippo; Sanguedolce, Francesco; Schiavina, Riccardo; Martorana, Giuseppe; Shariat, Shahrokh F.; Chun, Felix

Book ID: 120378364
Publisher: Lippincott Williams and Wilkins
Year: 2013
Tongue: English
Weight: 618 KB
Volume: 190
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2013.03.097

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SWOG S0353: Phase II Trial of Intravesic

SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer and Recurrence after 2 Prior Courses of Intravesical Bacillus Calmette-Guérin

✍ Skinner, Eila C.; Goldman, Bryan; Sakr, Wael A.; Petrylak, Daniel P.; Lenz, Hein 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 430 KB

Can Early Single Dose Instillation of Ep

Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study

✍ Cai, Tommaso; Nesi, Gabriella; Tinacci, Galliano; Zini, Enzo; Mondaini, Nicola; 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 218 KB

Re: Can Early Single Dose Instillation o

Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study

✍ Sylvester, Richard J.; Oosterlinck, Willem; O'Donnell, Michael 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 54 KB

Long-Term Efficacy Results of EORTC Geni

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Richard J. Sylvester; Maurizio A. Brausi; Wim J. Kirkels; Wolfgang Hoeltl; Ferna 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Re: Long-Term Efficacy Results of EORTC

Re: Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Donald L. Lamm 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Re: Long-Term Efficacy Results of EORTC

Re: Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin Plus Isoniazid in Patients With Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Wood, David P. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 52 KB